Morphologic heterogeneity of cell populations isolated by density gradient centrifugation from serous fluids of ovarian tumors. 1987

J Rabczynski, and J K Bar, and A Noworolska, and M Cislo, and R Richer, and A Harlozinska
Department of Pathological Anatomy, School of Medicine, Wroclaw, Poland.

The cells of tumor fluid from patients with malignant and benign serous ovarian neoplasms were fractionated using Ficoll-Uropoline density gradient centrifugation. Density distribution and morphologic characteristics of cell fractions were analyzed. It was found that serous ovarian adenocarcinomas contained three to four types of morphologically malignant cells focused in low density layers. Borderline ovarian neoplasms showed the presence of one subpopulation of cells with some features of malignancy and cells with some atypical but non-malignant features. The fluids of serous cysts contained mainly normal epithelial cells representing different stages of morphological maturity and were focused in denser layers. The results allowed us to catalogue ovarian tumor cell subpopulations present in each density fraction of individual patients and confirmed that ovarian tumors could be diagnosed by morphologic identification of cells from tumor fluids.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010048 Ovarian Cysts General term for CYSTS and cystic diseases of the OVARY. Corpus Luteum Cyst,Corpus Luteum Cysts,Cyst, Corpus Luteum,Cyst, Ovarian,Cysts, Corpus Luteum,Cysts, Ovarian,Ovarian Cyst
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002458 Cell Fractionation Techniques to partition various components of the cell into SUBCELLULAR FRACTIONS. Cell Fractionations,Fractionation, Cell,Fractionations, Cell
D002499 Centrifugation, Density Gradient Separation of particles according to density by employing a gradient of varying densities. At equilibrium each particle settles in the gradient at a point equal to its density. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Centrifugations, Density Gradient,Density Gradient Centrifugation,Density Gradient Centrifugations,Gradient Centrifugation, Density,Gradient Centrifugations, Density
D003536 Cystadenocarcinoma A malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur. Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. (Stedman, 25th ed) Cystadenocarcinomas
D003537 Cystadenoma A benign neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. In some instances, considerable portions of the neoplasm, or even the entire mass, may be cystic. (Stedman, 25th ed) Cystadenomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Rabczynski, and J K Bar, and A Noworolska, and M Cislo, and R Richer, and A Harlozinska
August 1994, Tumori,
J Rabczynski, and J K Bar, and A Noworolska, and M Cislo, and R Richer, and A Harlozinska
June 1973, Journal of immunology (Baltimore, Md. : 1950),
J Rabczynski, and J K Bar, and A Noworolska, and M Cislo, and R Richer, and A Harlozinska
September 1977, Experientia,
J Rabczynski, and J K Bar, and A Noworolska, and M Cislo, and R Richer, and A Harlozinska
August 1989, Acta endocrinologica,
J Rabczynski, and J K Bar, and A Noworolska, and M Cislo, and R Richer, and A Harlozinska
January 1989, Anticancer research,
J Rabczynski, and J K Bar, and A Noworolska, and M Cislo, and R Richer, and A Harlozinska
September 1987, Journal of leukocyte biology,
J Rabczynski, and J K Bar, and A Noworolska, and M Cislo, and R Richer, and A Harlozinska
May 1988, Endocrinology,
J Rabczynski, and J K Bar, and A Noworolska, and M Cislo, and R Richer, and A Harlozinska
December 1971, The Biochemical journal,
J Rabczynski, and J K Bar, and A Noworolska, and M Cislo, and R Richer, and A Harlozinska
May 1977, Brain research,
J Rabczynski, and J K Bar, and A Noworolska, and M Cislo, and R Richer, and A Harlozinska
July 1969, Bollettino della Societa italiana di biologia sperimentale,
Copied contents to your clipboard!